The Evolving Role of BTK Inhibitors in Treating Chronic Lymphocytic Leukemia
EP. 1: Rationale for BTK Inhibition in CLL
April 16th 2020
EP. 2: BTK Inhibition: Disease State Effectiveness
April 16th 2020
EP. 3: Approved BTK Inhibitors for CLL
April 16th 2020
EP. 4: CLL Frontline Options
April 16th 2020
EP. 5: CLL Subpopulations: Whom Not to Give BTK Inhibition To
April 16th 2020
EP. 6: Time-Limited Therapy Options for BTK Inhibitors
April 16th 2020
EP. 7: BTK Combination Therapy
April 16th 2020
EP. 8: BTK Inhibition: Real World vs Clinical Experience
April 16th 2020
EP. 9: The Management of Cardiovascular Events
April 16th 2020
EP. 10: BTK Inhibitor Resistance and Progression
April 16th 2020
EP. 11: The Future of CLL Management
April 16th 2020
